Company Filing History:
3 out of 4 
1 out of 1 
1 out of 1 Years Active: 2015-2020
Title: The Innovative Contributions of Eugene Zhukovsky
Introduction
Eugene Zhukovsky is a notable inventor based in Mannheim, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of binding proteins for cancer immunotherapy. With a total of 5 patents, his work has the potential to impact the treatment of various cancers.
Latest Patents
Among his latest patents is the development of bispecific CD33 and CD3 binding proteins. These proteins are designed to specifically bind to human CD33, which is crucial for the immunotherapy of cancers such as acute myeloid leukemia (AML). Additionally, he has worked on antibody binding sites specific for EGFRvIII, which includes multispecific binding proteins that target both EGFRvIII and CD3. This innovation aims to create highly cytotoxic bispecific tandem diabodies that can effectively recruit T cells to eliminate solid tumor cancers.
Career Highlights
Eugene has worked with several prominent companies in the biotechnology sector, including Amphivena Therapeutics, Inc. and Affirmed GmbH. His experience in these organizations has allowed him to refine his expertise in the development of therapeutic proteins.
Collaborations
Eugene has collaborated with talented individuals such as Kristina Ellwanger and Ivica Fucek. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Eugene Zhukovsky's innovative work in the field of binding proteins showcases his commitment to advancing cancer treatment. His contributions are paving the way for new therapeutic options that could significantly improve patient outcomes.